Mitsubishi Tanabe And Daiichi Sankyo Sign Diabetes Co-Promotion Deal
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo and Mitsubishi Tanabe Pharma Corp have signed a strategic sales agreement for novel diabetes agents developed by the two companies.